| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:42 | Worksport expands operations with new Missouri facility for solar covers | ||
| 14:42 | Old Mutual reports marginal growth in life sales, pressure on cash flow | ||
| 14:42 | Etihad Airways expands Viasat connectivity across entire fleet | ||
| 14:42 | Lipocine reports positive safety review for PPD treatment in phase 3 trial | ||
| 14:42 | Innventure appoints Bruce Brown as first lead independent director | ||
| 14:42 | Bernstein sees hotel owner returns declining as industry faces headwinds | ||
| 14:42 | Bernstein reiterates Outperform rating on IAG stock ahead of potential TAP acquisition | ||
| 14:42 | Stifel reiterates Buy rating on Elanco Animal Health stock, maintains $27 price target | ||
| 14:42 | XPeng stock holds steady as Bernstein reiterates Market Perform rating | ||
| 14:42 | Stifel reiterates Buy rating on NETGEAR stock, maintains $40 price target | ||
| 14:42 | Stifel reiterates Buy rating on Autodesk stock ahead of Q3 earnings | ||
| 14:42 | Bernstein raises Atlassian stock price target to $304 on Data Center EOL impact | ||
| 14:42 | Stifel reiterates Buy rating on IDEXX Laboratories stock, maintains $775 price target | ||
| 14:42 | Stifel lowers Trupanion stock price target to $42 on consumer spending limits | ||
| 14:42 | Stifel lowers Zoetis stock price target to $130 on margin concerns | ||
| 14:18 | Toyota boosts hybrid production with $912 million investment | ||
| 14:18 | Acumen to present Alzheimer's drug findings at CTAD conference | ||
| 14:18 | Emergent's NARCAN nasal spray marks 10 years since FDA approval | ||
| 14:18 | FDA schedules meeting with Annovis Bio on Parkinson's disease dementia | ||
| 14:18 | Armis cyber exposure tech now runs on Keysight network devices | ||
| 14:18 | Nasus Pharma begins phase 2 trial of needle-free epinephrine for anaphylaxis | ||
| 14:18 | Ardent Health authorizes $50 million share repurchase program | ||
| 14:18 | Nanox.AI partners with 3DR Labs to expand AI imaging reach | ||
| 14:18 | Salesforce completes acquisition of Informatica to boost AI capabilities | ||
| 14:18 | CytoMed acquires TC BioPharm's gamma delta T cell technology |